Estimation of the prevalence of amyotrophic lateral sclerosis in the United States using national administrative healthcare data from 2002 to 2004 and capture-recapture methodology

At a glance

Estimating prevalence of ALS in the United States using administrative health data

Affiliates

Lorene M. Nelson1, Barbara Topol1, Wendy Kaye2, David Williamson3, D. Kevin Horton3, Paul Mehta3, and Todd Wagner1,4

  1. Department of Health Research and Policy, Stanford School of Medicine
  2. McKing Consulting Corporation
  3. Agency for Toxic Substances and Disease Registry, Division of Toxicology and Human Health Sciences
  4. Health Economics Resource Center (HERC), Veterans Affairs Palo Alto Health Care System

Journal

Neuroepidemiology

Summary

This study used three sources (Medicare, Medicaid, and Veterans Administration data) to locate PALS and estimate the prevalence of ALS in the United States for 2002–2004. Additionally, it applied a capture-recapture methodology to estimate the degree to which cases were missing when relying solely on these sources for case identification. Case-finding completeness was 76% overall; this did not vary by race, but by gender and age. Findings from this study suggest that federal healthcare claims databases are very efficient for identifying the majority of ALS-prevalent cases in the National ALS Registry; however, they can be enhanced via patient self-registration in the Registry portal.

Link to paper

Find the paper here!

Print
Content Source:
Agency for Toxic Substances and Disease Registry